Chronic kidney disease in isolated core antibody positive hepatitis B patients: Risk analysis from NHANES 2017-2020

Ke Mi1, Tingdan Ye1, Calvin Q Pan2

  • 1Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Insights

Isolated hepatitis B core antibody (HBcAb) positivity did not show a positive association with chronic kidney disease (CKD) risk in US adults. However, older age and elevated serum urea nitrogen were linked to higher CKD risk in this group.

Area of Science:

  • Nephrology
  • Hepatology
  • Epidemiology

Background:

  • The link between isolated hepatitis B core antibody (HBcAb) positivity and chronic kidney disease (CKD) is debated.
  • Some studies suggest a connection between hepatitis B virus (HBV) infection and increased CKD risk, while others present inconclusive findings.
  • This research investigates the association between isolated HBcAb positivity and CKD within the U.S. population.

Purpose of the Study:

  • To evaluate the association between isolated HBcAb positivity and the prevalence of CKD in U.S. adults.
  • To identify risk factors for CKD among individuals with isolated HBcAb positivity.

Main Methods:

  • Analysis of data from adult participants in the NHANES 2017-2020 cycle.
  • Categorization of participants into isolated HBcAb positive and non-infected groups.
  • Use of logistic regression models to assess the association between isolated HBcAb positivity and CKD, with multivariate analysis to identify risk factors.

Main Results:

  • CKD prevalence was higher in the isolated HBcAb positive group (7.9%) compared to the non-infected group (5.2%).
  • Unadjusted analysis indicated an increased CKD risk with isolated HBcAb positivity (OR=1.25), but adjusted analyses revealed an inverse association (OR=0.76).
  • Among isolated HBcAb positive individuals, older age and elevated serum urea nitrogen (BUN) were associated with higher CKD risk, while higher education was associated with reduced risk.

Conclusions:

  • Despite higher CKD prevalence in the isolated HBcAb positive group, no positive association with CKD risk was found after adjustment.
  • Older age and elevated BUN levels are significant risk factors for CKD in this population.
  • Findings emphasize the need for individualized monitoring and management strategies for HBV-infected patients, particularly concerning antiviral therapy and post-cure follow-up.
Abstract

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...